Complete Study of Coronavac Vaccine Will Be Revealed on December 23

SP postpones disclosure of Covid vaccine efficacy to send data to China and studies reaction of STF against Bolsonaro government

São Paulo

Confident in the high effectiveness of Coronavac, the government of São Paulo changed its tactic to pressure Anvisa (National Health Surveillance Agency) to approve the vaccine against Covid-19 later this year.

If that fails, however, judicial measures are already being studied to take the "vaccine war" between President Jair Bolsonaro (without a party) and Governor João Doria (PSDB-SP) to the Supreme Court.

File photo: Sao Paulo Governor Joao Doria (C), Sao Paulo state Health Secretary Dr. Jean Gorinchteyn (L), and Butantan Institute Director Dimas Covas (R), pose for photos next to a container carrying doses of the CoronaVac vaccine after it was unloaded from a cargo plane that arrived from China at Guarulhos International Airport in Guarulhos, near Sao Paulo, Brazil, on December 03, 2020. - Brazil received this Thursday the second lot with 600 liters of the CoronaVac vaccine, developed by the Chinese laboratory Sinovac Biotech. (Photo by NELSON ALMEIDA / AFP) - AFP

The state was supposed to disclose the preliminary effectiveness of phase 3 on Tuesday (15). Still, the state will wait until the 23rd and present the complete trial to request the Chinese vaccine's approval by Anvisa.

In addition, in agreement with the Chinese manufacturer Sinovac, the vaccine will seek approval with NMPA (National Administration of Medical Products), Anvisa of the Asian country.

It is expected that China will register Coronavac in about three days.

Translated by Kiratiana Freelon

Read the article in the original language